首页> 外文期刊>Urologic oncology >Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma
【24h】

Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma

机译:先前或同期膀胱癌对上尿路尿路上皮癌根治性肾切除术后肿瘤结局的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: The objective of the study was to evaluate the effect of a history of bladder cancer (BC) or synchronous BC on the prognosis and survival of patients who have undergone radical nephroureterectomy (RNU). Methods and materials: Using a multi-institutional, retrospective database, we identified 662 patients with upper urinary tract urothelial carcinoma (UUT-UC) treated by radical nephroureterectomy, between 1995 and 2010. We analyzed clinicopathologic characteristics and outcomes according to the history of BC or concomitant BC or both, at the time of diagnosis. BC was evaluated as a prognostic factor for bladder recurrence and survival. Results: Overall, 83 (12.5%) patients had previous BC, 62 (9.4%) exhibited concomitant BC, and 75 (11.3%) presented with both previous and current BC. A history of BC was less seen in women and nonsmokers (P<0.0001 and P = 0.013, respectively). The patients with associated BC had more tumors located in the ureter (P<0.0001), as well as more multiple locations in the upper tract (P<0.0001). The tumors without concomitant BC were more likely to be associated with locally advanced stages (P = 0.024). At a median follow-up time of 37.3 months, 31.4% of patients experienced BC recurrence and 2.9% developed contralateral upper tract tumor. Using multivariate analyses, the previous or synchronous BC (P = 0.01) and positive surgical margins (P = 0.03) are independent prognostic factors for BC recurrence. The metastasis-free survival and cancer-specific survival rates did not significantly differ according to the associated BC status. Conclusions: In patients without previous or concomitant BC, the upper tract tumors are more frequently localized in the renal pelvis and are associated with a more invasive status at the time of diagnosis. Nevertheless, the presence of UUT-UC without previous or synchronous BC did not significantly affect the survival rates after nephroureterectomy.
机译:目的:本研究的目的是评估膀胱癌病史(BC)或同步性BC对行根治性肾切除术(RNU)的患者的预后和生存的影响。方法和材料:使用多机构回顾性数据库,我们从1995年至2010年间确定了662例行根治性肾切除术治疗的上尿路尿路上皮癌(UUT-UC)患者。我们根据BC的病史分析了其临床病理特征和预后或在诊断时同时伴有BC或两者兼有。 BC被评估为膀胱复发和生存的预后因素。结果:总体上,有83例(12.5%)既往有BC,62例(9.4%)表现为伴随性BC,而75例(11.3%)既有BC也有当前BC。女性和非吸烟者的BC史较少(分别为P <0.0001和P = 0.013)。伴有BC的患者在输尿管中有更多的肿瘤(P <0.0001),在上尿道中有更多的多个位置(P <0.0001)。不伴有BC的肿瘤更可能与局部晚期相关(P = 0.024)。中位随访时间为37.3个月,有31.4%的患者出现BC复发,而2.9%的患者发展了对侧上道肿瘤。使用多变量分析,先前或同步的BC(P = 0.01)和手术切缘阳性(P = 0.03)是BC复发的独立预后因素。根据相关的BC状态,无转移生存率和癌症特异性生存率没有显着差异。结论:在没有先前或伴随BC的患者中,上道肿瘤更常见于肾盂,并在诊断时与更具侵袭性的状态相关。然而,不存在既往或同步BC的UUT-UC的存在并没有显着影响肾结直肠癌切除术后的存活率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号